Melhores Cancro do cólon médicos em Israel - TOP-24 médicos

A Dra. Pelles Sharon formou-se no Royal Marsden – o principal centro de oncologia da Europa – especializando-se em cancros gastrointestinais. Dirige o Instituto de Tumores do Sistema Digestivo em Ichilov.

• Ser especialista em HIPEC e terapias direcionadas para o cancro colorretal
• Lecionar na Escola de Medicina da Universidade de Tel Aviv
• Ser investigadora publicada sobre tratamentos de adenocarcinoma pancreático
• Ser membro da Associação de Oncologia e Radiologia de Israel

O Prof. Ofer Merimsky lidera a Unidade de Oncologia de Partes Moles e Óssea no Sourasky Medical Center – um dos principais hospitais de oncologia de Israel.

• Mais de 30 anos de especialização em sarcomas e casos de tumores complexos
• Formação especializada (Fellowship) no Institut Gustave Roussy, o principal centro de oncologia da Europa
• Membro do corpo docente da ESMO para protocolos de tratamento de sarcomas
• Publicar pesquisas extensas sobre terapias oncológicas inovadoras

O Prof. Nadir Arber lidera um dos poucos centros dedicados à prevenção do câncer em Israel, concentrando-se exclusivamente em interromper o câncer antes que ele comece.

• Mais de 30 anos de experiência no tratamento de tumores do trato gastrointestinal
• Autor de mais de 300 artigos científicos sobre prevenção do câncer e terapia gênica
• Chefiar o Centro Integrado de Prevenção do Câncer no Tel Aviv Sourasky Medical Center
• Manter filiações nas principais associações internacionais de oncologia e gastroenterologia
• Concluir trabalhos de pesquisa no prestigioso NewYork-Presbyterian Center

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

O Professor Ido Wolf chefia todo o departamento de oncologia do Centro Médico de Tel Aviv, um dos principais hospitais de Israel. Ele possui experiência específica no tratamento de tumores colorretais e hepáticos.

• Chefiar a Divisão de Oncologia Médica no Centro Médico Sourasky (Ichilov)
• Possuir mais de 20 anos de experiência em oncologia e medicina interna
• Formação médica na prestigiada Faculdade de Medicina Sackler, Universidade de Tel Aviv
• Especializar-se no diagnóstico complexo e tratamento de cancros gastrointestinais

O Professor Tulchinsky é o Diretor da Unidade de Cirurgia do Cólon e Reto e Chefe da Divisão de Cirurgia Geral do Centro Médico Sourasky de Tel Aviv.

• Especialista líder em doenças colorretais e anais, incluindo cancro
• Realizar cirurgias reconstrutivas para cancro retal e condições familiares
• Especializar-se em resseções intestinais laparoscópicas minimamente invasivas
• A unidade é líder em procedimentos colorretais diagnósticos e terapêuticos

Diretor de internação oncológica no Centro Médico de Tel Aviv, Ichilov – O Dr. Stepfansky tem mais de 20 anos de experiência em oncologia.

• Especializar-se em oncologia no Centro Médico de Tel Aviv
• Pesquisador principal em estudos de oncologia clínica
• Certificado em medicina interna e oncologia
• Reconhecido por casos complexos de cancro do cólon

Chefe do Departamento de Cirurgia Colorretal do Sourasky Medical Center – um especialista de renome com mais de 20 anos de experiência cirúrgica.

• Especialista em técnicas cirúrgicas abertas e minimamente invasivas
• Realizar procedimentos complexos, como a cirurgia de Whipple
• Concentrar-se exclusivamente em cirurgia abdominal e colorretal

Especialista focado exclusivamente em cirurgia de cancro do cólon, com mais de 25 anos de prática académica e clínica. É Diretor do Programa de Residência em Cirurgia no Hadassah Medical Center.

• Certificado pelo conselho de especialidade de Israel em Cirurgia Geral desde 1998
• Instrutor, conferencista e professor sénior de cirurgia há décadas
• Membro de várias associações cirúrgicas prestigiadas
• Fluente em inglês e hebraico para comunicação com o paciente

O Dr. Auala Hubert chefia o Centro de Cancro Gastrointestinal do Centro Médico Hadassah, especializando-se em cancro do cólon.

• Ter 33 anos de experiência em oncologia e radioterapia
• Possuir certificações de especialidade tanto em oncologia como em radioterapia
• Atuar como médico sénior no Hospital Universitário Hadassah
• Ser membro do Comité de Cancro Gastrointestinal em Israel
• Formar-se em medicina no prestigiado Hospital Universitário Hadassah

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Vice-Chefe do Departamento de Oncologia – um cargo de liderança sênior que supervisiona o tratamento complexo do cancro no Rambam Medical Center.

• Especializar-se no tratamento de pacientes com cancro do cólon
• Trabalhar no Rambam – um hospital terciário de referência em Israel
• Ocupar um cargo sénior na orientação de protocolos de tratamento e investigação

O Dr. Alexander Beny dirige o Serviço de Malignidade Gastrointestinal no Rambam Medical Center, trazendo décadas de experiência focada em cancro do cólon.

• Possui certificações europeias e israelitas em oncologia
• Diretor do Serviço de Malignidade Gastrointestinal – especializado em cancros digestivos
• Dirige uma clínica dedicada à Oncologia Gastrointestinal
• Formação avançada concluída em técnicas modernas de radioterapia
• Médico Sénior no Departamento de Oncologia com vasta experiência clínica